AZ’s COVID-19 vaccine trial ready to resume in US – reportsAstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus Share XAZ’s COVID-19 vaccine trial ready to resume in US – reportshttps://pharmaphorum.com/news/azs-covid-19-vaccine-trial-ready-to-resume-reports/
FDA grants fast review for AstraZeneca’s Tagrisso in early-stage lung cancerThe FDA has granted a fast review for AstraZeneca’s Tagrisso oncology drug in certain patients with early-stage lung Share XFDA grants fast review for AstraZeneca’s Tagrisso in early-stage lung cancerhttps://pharmaphorum.com/news/fda-grants-fast-review-for-astrazenecas-tagrisso-in-early-stage-lung-cancer/
UK government signs contract for COVID-19 challenge trialThe UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will Share XUK government signs contract for COVID-19 challenge trialhttps://pharmaphorum.com/news/uk-government-signs-contract-for-covid-19-challenge-trial/
Pfizer to wait until after election to file COVID-19 vaccine in USPfizer said it will wait until after the US election to file its COVID-19 vaccine with the US Share XPfizer to wait until after election to file COVID-19 vaccine in UShttps://pharmaphorum.com/news/pfizer-to-wait-until-after-election-to-file-covid-19-vaccine-in-us/
Spotlight on COVID-19 antibody therapies after Trump’s recoveryThe spotlight remains on the potential of antibody therapies as a possible way out of the COVID-19 pandemic Share XSpotlight on COVID-19 antibody therapies after Trump’s recoveryhttps://pharmaphorum.com/news/spotlight-on-covid-19-antibody-therapies-after-trumps-recovery/
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jabThe European Medicines Agency has begun a second “rolling review” of a potential coronavirus vaccine jointly developed by Share XRace for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jabhttps://pharmaphorum.com/news/ema-begins-rolling-review-biontech-pfizers-covid-19-shot/
Older people first to receive COVID-19 vaccine in UK, says governmentAs European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted Share XOlder people first to receive COVID-19 vaccine in UK, says governmenthttps://pharmaphorum.com/news/older-people-and-health-workers-first-to-receive-covid-19-vaccine-government/
European regulators begin rolling review of AZ’s COVID-19 vaccineEuropean regulators have started a first ‘rolling review’ of a COVID-19 vaccine, which is being developed by AstraZeneca Share XEuropean regulators begin rolling review of AZ’s COVID-19 vaccinehttps://pharmaphorum.com/news/european-regulators-begin-rolling-review-of-azs-covid-19-vaccine/
EMA review of AZ’s COVID-19 vaccine imminent; reportThe EU regulator is poised to start a review of AstraZeneca and Oxford University’s COVID-19 vaccine, but the Share XEMA review of AZ’s COVID-19 vaccine imminent; reporthttps://pharmaphorum.com/news/ema-review-of-azs-covid-19-vaccine-imminent-report/
